With artificial intelligence (AI) fast becoming an ubiquitous part of everyday life, its further application in clinical ...

Over the last several months, a deep sense of unease has settled over laboratories across the United States. Researchers at ...

ICON was also recognised as a Top-Rated Company for Women in the 2025 Ambition Box Employee Choice Awards. This recognition is based on feedback shared by ICON employees in India and reflects the ...

Lorenzo Thompson, M.D. The HDC wants this success to grow as more UAB researchers learn about this helpful tool, say Lund and Lorenzo Thompson, M.D., the institute’s clinical research administrative ...

BUFFALO, N.Y. and MORRISVILLE, N.C., June 09, 2025 (GLOBE NEWSWIRE) -- Today, Lightship and Circuit Clinical proudly announce their strategic merger, forming a leading, unified force in clinical ...

Why Texas is spending millions to research an illegal psychedelic Ibogaine is illegal in the United States, but Texas is on the verge of spending up to $50 million to jumpstart clinical trials.

McGill University. "Clinical research on psychedelics gets a boost from new study." ScienceDaily. ScienceDaily, 3 June 2025. <www.sciencedaily.com / releases / 2025 / 06 / 250603114816.htm>.

Expert responses regarding the separability and conceptual overlap of set and setting factors, and temporal span of setting in psychedelic clinical trials. Credit: Nature Medicine (2025). DOI: 10. ...

On 29 May 2025, the Health Systems Research Institute (HSRI) and Novo Nordisk Pharma (Thailand) Ltd. “Novo Nordisk” —entered into a Memorandum of Understanding (MoU) to collaborate on ...

Sobi® (STO: SOBI) will present new clinical data and research outcomes at the annual European Congress of Rheumatology (EULAR 2025) in Barcelona from the 11-14 June 2025. Research will include ...

Prof Coleman moved to Yorkshire in the early 1990s to head up a new cancer clinical research facility in Sheffield, which was later supported by funding from Yorkshire Cancer Research. By 2000 ...

It’s estimated that at least 1 in 5 people with cancer in the US participate in some form of medical research. “Clinical trials are a key part of delivery of care to patients.